Intellectual disability without epilepsy associated with STXBP1 disruption.

Area of Science:

• Neurogenetics
• Molecular Neuroscience
• Epilepsy Research

Background:

• STXBP1 (Munc18-1) is crucial for neurotransmitter release via vesicle fusion.
• De novo STXBP1 mutations are linked to Ohtahara syndrome and intellectual disability with epilepsy.
• The full spectrum of STXBP1-associated neurological disorders is not yet defined.

Purpose of the Study:

• To investigate STXBP1 mutations in patients with non-syndromic intellectual disability (NSID).
• To identify novel mutations and expand the understanding of STXBP1's role in neurological phenotypes.
• To characterize the clinical presentation associated with a newly identified STXBP1 mutation.

Main Methods:

• Exome sequencing of the STXBP1 gene in 50 patients with NSID.
• Segregation analysis to confirm de novo status of identified mutations.
• Clinical evaluation of patients, including detailed neurological and epilepsy history.

Main Results:

• A novel de novo truncating mutation (c.1206delT/p.Y402X) in STXBP1 was identified in one patient with NSID.
• This patient presented with intellectual disability but notably lacked any history of epilepsy.
• This finding contrasts with previously reported truncating mutations in STXBP1, which were associated with epilepsy.

Conclusions:

• STXBP1 disruption can lead to intellectual disability without epilepsy, broadening the clinical spectrum.
• The study highlights the variability in phenotypic expression of STXBP1 mutations.
• Further research is needed to understand the mechanisms underlying the diverse neurological outcomes associated with STXBP1 variants.